Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX®) and the PAM50 breast cancer intrinsic classifier in early-stage estrogen receptor-positive breast cancer

Catherine M. Kelly, Philip S. Bernard, Savitri Krishnamurthy, Bailiang Wang, Mark T.W. Ebbert, Roy R.L. Bastien, Kenneth M. Boucher, Elliana Young, Takayuki Iwamoto, Lajos Pusztai

Research output: Contribution to journalArticlepeer-review

62 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX®) and the PAM50 breast cancer intrinsic classifier in early-stage estrogen receptor-positive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences